Please wait while the formulary information is being retrieved.
DYMISTA (AZELASTINE HCL/FLUTICASONE PROPIONATE)
- Allergic conjunctivitis
- Seasonal allergic rhinitis
137 mcg-50 mcg/spray nasal spray
- Spray 1 spray in each nostril by intranasal route 2 times per day
Allergic conjunctivitis
- Spray 1 spray in each nostril by intranasal route 2 times per day
Seasonal allergic rhinitis
- Spray 1 spray in each nostril by intranasal route 2 times per day
- None
Contraindicated
- boceprevir
- elvitegr-cobicist-emtric-tenof
- Incivek
- Kaletra
- Korlym
- lopinavir-ritonavir
- Mifeprex
- mifepristone
- Norvir
- Norvir Soft Gelatin
- ritonavir
- Stribild
- telaprevir
- Victrelis
Severe
Moderate
- amoxicil-clarithromy-lansopraz
- Biaxin
- Biaxin Xl
- Biaxin Xl Pak
- clarithromycin
- Erythrocin
- erythromycin
- erythromycin-sulfisoxazole
- itraconazole
- ketoconazole
- Omeclamox-pak
- omeprazole-clarith-amoxicillin
- Onmel
- Prevpac
- Sporanox
- Sporanox Pulsepak
- None
Contraindicated
- Active tuberculosis
- Measles
- Nasal septal perforation
- Nasal septal ulcers
- Nasal trauma
- Ocular herpes simplex
- Ocular hypertension
- Open angle glaucoma
- Operation on nose
- Varicella zoster virus infection
Severe
Moderate
- Adrenal cortical insufficiency
- Cataracts
- Drowsy
- Epistaxis
- Inactive tuberculosis
- Nasal candidiasis
- Parasitic infection
DYMISTA (AZELASTINE HCL/FLUTICASONE PROPIONATE)
- Allergic conjunctivitis
- Seasonal allergic rhinitis
- None
- Drowsy
- Dry nose
- Dysesthesia
- Dysgeusia
- Epistaxis
- Headache disorder
- Nasal passage irritation
- Pharyngitis
More Frequent
Severe
Less Severe
- Bronchitis
- Cough
- Dizziness
- Lesion of nasal mucosa
- Urticaria
- Conjunctivitis
- Cough
- Crusted nasal mucosa
- Dizziness
- Dysgeusia
- Epistaxis
- Fatigue
- Fever
- Myalgias
- Nasal congestion
- Nasal pain
- Nasal passage irritation
- Nausea
- Pharyngitis
- Rhinitis
- Rhinorrhea
- Sinusitis
- Sneezing
- Sore throat
- Vomiting
- Weight gain
- Xerostomia
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Adrenal cortical insufficiency
- Anaphylaxis
- Angioedema
- Atrial fibrillation
- Blurred vision
- Bronchospastic pulmonary disease
- Cataracts
- Contact dermatitis
- Glaucoma
- Hematuria
- Hypercortisolism
- Immunosuppression
- Impaired wound healing
- Nasal candidiasis
- Nasal septal perforation
- Ocular pain
- Pharyngeal candidiasis
- Pruritus of skin
- Skin rash
- Stomatitis
- Tachycardia
- Urinary retention
- Visual changes
- Wheezing
Less Severe
- Abdominal pain with cramps
- Acute confusion
- Aphthous stomatitis
- Blurred vision
- Chest pain
- Conjunctivitis
- Constipation
- Contact dermatitis
- Depression
- Diarrhea
- Dry eye
- Dyspnea
- Eczema
- Eye tearing
- Facial edema
- Flu-like symptoms
- Flushing
- Folliculitis
- Furunculosis
- Gastroenteritis
- Glossitis
- Hyperkinesis
- Hypertension
- Hypesthesia
- Increased appetite
- Lacerations
- Lesion of nasal mucosa
- Loss of sense of smell
- Nervousness
- Palpitations
- Paresthesia
- Parosmia
- Sleep disorder
- Symptoms of anxiety
- Toothache
- Vomiting
Contraindicated
None
Severe Precaution
Fluticasone Propionate (Nasal)
May slow growth rate. Safety and efficacy not established age less than 4 years.
- 1 Day – 4 Years
- May slow growth rate. Safety and efficacy not established age less than 4 years.
Management or Monitoring Precaution
Azelastine (0.15% or combination)
Safety and efficacy not established age < 6 years. 0.1% azelastine approved for age 6 months and older.
May reduce growth rate; monitor growth and use lowest effective dose.
- 1 Day – 6 Years
- Safety and efficacy not established age < 6 years. 0.1% azelastine approved for age 6 months and older.
- 4 Years – 18 Years
- Safety and efficacy not established age < 6 years. 0.1% azelastine approved for age 6 months and older.
Fluticasone Propionate(Nasal)
Safety and efficacy not established age < 6 years. 0.1% azelastine approved for age 6 months and older.
May reduce growth rate; monitor growth and use lowest effective dose.
- 1 Day – 6 Years
- May reduce growth rate; monitor growth and use lowest effective dose.
- 4 Years – 18 Years
- May reduce growth rate; monitor growth and use lowest effective dose.
Azelastine
- Severity Level:
2
- Additional Notes: Insufficient human data available.
Fluticasone (nasal)
- Severity Level:
2
- Additional Notes: Insufficient human data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Azelastine
Insufficient data available.
Systemic products excreted in rats; caution advised with nasal administration
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available. |
Fluticasone (inhal, Nasal)
Insufficient data available.
Systemic products excreted in rats; caution advised with nasal administration
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Systemic products excreted in rats; caution advised with nasal administration |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Allergic conjunctivitis | |
| H10.1 | Acute atopic conjunctivitis |
| H10.10 | Acute atopic conjunctivitis, unspecified eye |
| H10.11 | Acute atopic conjunctivitis, right eye |
| H10.12 | Acute atopic conjunctivitis, left eye |
| H10.13 | Acute atopic conjunctivitis, bilateral |
| H10.44 | Vernal conjunctivitis |
| H10.45 | Other chronic allergic conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
| Seasonal allergic rhinitis | |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
| 0-9 | A-Z |
|---|---|
| H10.1 | Acute atopic conjunctivitis |
| H10.10 | Acute atopic conjunctivitis, unspecified eye |
| H10.11 | Acute atopic conjunctivitis, right eye |
| H10.12 | Acute atopic conjunctivitis, left eye |
| H10.13 | Acute atopic conjunctivitis, bilateral |
| H10.44 | Vernal conjunctivitis |
| H10.45 | Other chronic allergic conjunctivitis |
| H16.26 | Vernal keratoconjunctivitis, with limbar and corneal involvement |
| H16.261 | Vernal keratoconjunctivitis, with limbar and corneal involvement, right eye |
| H16.262 | Vernal keratoconjunctivitis, with limbar and corneal involvement, left eye |
| H16.263 | Vernal keratoconjunctivitis, with limbar and corneal involvement, bilateral |
| H16.269 | Vernal keratoconjunctivitis, with limbar and corneal involvement, unspecified eye |
| J30.1 | Allergic rhinitis due to pollen |
| J30.2 | Other seasonal allergic rhinitis |
Formulary Reference Tool